Panacea Biotec Limited (PANACEABIO.BO)

INR 465.0

(2.69%)

Long Term Debt Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual long term debt in 2023 was 209.9 Million INR , up 4.1% from previous year.
Panacea Biotec Limited's latest quarterly long term debt in 2023 FY was 209.9 Million INR , up 4.1% from previous quarter.
Panacea Biotec Limited reported annual long term debt of 201.64 Million INR in 2022, down -40.87% from previous year.
Panacea Biotec Limited reported annual long term debt of 341.03 Million INR in 2021, down -95.36% from previous year.
Panacea Biotec Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.
Panacea Biotec Limited reported quarterly long term debt of 209.9 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Long Term Debt of Panacea Biotec Limited (2023 - 2004)

Year	Long Term Debt	Long Term Debt Growth
2023	209.9 Million INR	4.1%
2022	201.64 Million INR	-40.87%
2021	341.03 Million INR	-95.36%
2020	7.35 Billion INR	19.89%
2019	6.13 Billion INR	1229.36%
2018	461.22 Million INR	-91.92%
2017	5.7 Billion INR	-20.08%
2016	7.14 Billion INR	-9.12%
2015	7.85 Billion INR	8.68%
2014	7.22 Billion INR	23.97%
2013	5.83 Billion INR	-15.47%
2012	6.89 Billion INR	34.61%
2011	5.12 Billion INR	20.96%
2010	4.23 Billion INR	-39.94%
2009	7.05 Billion INR	0.35%
2008	7.03 Billion INR	76.37%
2007	3.98 Billion INR	87.17%
2006	2.12 Billion INR	-63.67%
2005	5.86 Billion INR	263.81%
2004	1.61 Billion INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 FY	209.9 Million INR	4.1%
2023 Q1	- INR	-100.0%
2023 Q4	209.9 Million INR	0.0%
2023 Q2	206.2 Million INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	322.8 Million INR	0.0%
2022 Q4	201.64 Million INR	0.0%
2022 FY	201.64 Million INR	-40.87%
2021 Q3	- INR	-100.0%
2021 FY	341.03 Million INR	-95.36%
2021 Q4	341.03 Million INR	0.0%
2021 Q2	7.34 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q2	6.4 Billion INR	0.0%
2020 Q4	7.35 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	7.35 Billion INR	19.89%
2020 Q3	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 FY	6.13 Billion INR	1229.36%
2019 Q1	- INR	-100.0%
2019 Q2	6.54 Billion INR	0.0%
2019 Q4	6.13 Billion INR	0.0%
2018 Q4	461.22 Million INR	0.0%
2018 FY	461.22 Million INR	-91.92%
2017 FY	5.7 Billion INR	-20.08%
2016 FY	7.14 Billion INR	-9.12%
2015 FY	7.85 Billion INR	8.68%
2014 FY	7.22 Billion INR	23.97%
2013 FY	5.83 Billion INR	-15.47%
2012 FY	6.89 Billion INR	34.61%
2011 FY	5.12 Billion INR	20.96%
2010 FY	4.23 Billion INR	-39.94%
2009 FY	7.05 Billion INR	0.35%
2008 FY	7.03 Billion INR	76.37%
2007 FY	3.98 Billion INR	87.17%
2006 FY	2.12 Billion INR	-63.67%
2005 FY	5.86 Billion INR	263.81%
2004 FY	1.61 Billion INR	0.0%

Peer Long Term Debt Comparison of Panacea Biotec Limited

Name	Long Term Debt	Long Term Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	84.526%
Biocon Limited	129.32 Billion INR	99.838%
Blue Jet Healthcare Limited	3.79 Million INR	-5438.259%
Concord Biotech Limited	18.87 Million INR	-1012.348%
Dishman Carbogen Amcis Limited	2.45 Billion INR	91.454%
FERMENTA BIOTECH LIMITED	425.36 Million INR	50.654%
GENOMIC VALLEY BIOTECH LIMITED	- INR	-Infinity%
Lyka Labs Limited	429.06 Million INR	51.08%
SAMSRITA LABS LIMITED	- INR	-Infinity%
Servoteach Industries Limited	5059.00 INR	-4148941.313%
SMS Lifesciences India Limited	331.45 Million INR	36.672%
Supriya Lifescience Limited	50.2 Million INR	-318.127%
Syngene International Limited	1 Billion INR	79.01%
TAKE Solutions Limited	7.5 Million INR	-2698.667%
Titan Biotech Limited	4.53 Million INR	-4530.488%
Transgene Biotek Limited	50.79 Million INR	-313.23%
Vanta Bioscience Limited	488.01 Million INR	56.989%